Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept Study.
J Drugs Dermatol. 2015 Oct;14(10):1108-12.
J Drugs Dermatol. 2015.
PMID: 26461821
Clinical Trial.